Suppr超能文献

功能和非功能蛋白酶的计算机模拟研究与表征

In Silico Survey and Characterization of Functional and Non-Functional Proteases.

作者信息

Florin-Christensen Monica, Wieser Sarah N, Suarez Carlos E, Schnittger Leonhard

机构信息

Instituto de Patobiologia Veterinaria (IPVET), Centro de Investigaciones en Ciencias Veterinarias y Agronomicas, Instituto Nacional de Tecnología Agropecuaria (INTA), Hurlingham C1033AAE, Argentina.

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1033AAJ, Argentina.

出版信息

Pathogens. 2021 Nov 10;10(11):1457. doi: 10.3390/pathogens10111457.

Abstract

Human babesiosis caused by the intraerythrocytic apicomplexan is an expanding tick-borne zoonotic disease that may cause severe symptoms and death in elderly or immunocompromised individuals. In light of an increasing resistance of to drugs, there is a lack of therapeutic alternatives. Species-specific proteases are essential for parasite survival and possible chemotherapeutic targets. However, the repertoire of proteases in remains poorly investigated. Herein, we employed several combined bioinformatics tools and strategies to organize and identify genes encoding for the full repertoire of proteases in the genome. We identified 64 active proteases and 25 nonactive protease homologs. These proteases can be classified into cysteine ( = 28), serine ( = 21), threonine ( = 14), asparagine ( = 7), and metallopeptidases ( = 19), which, in turn, are assigned to a total of 38 peptidase families. Comparative studies between the repertoire of and proteases revealed differences among sensu stricto and sensu lato parasites that reflect their distinct evolutionary history. Overall, this data may help direct future research towards our understanding of the biology and pathogenicity of parasites and to explore proteases as targets for developing novel therapeutic interventions.

摘要

由红细胞内顶复门原虫引起的人类巴贝斯虫病是一种不断蔓延的蜱传人畜共患病,可能导致老年人或免疫功能低下者出现严重症状甚至死亡。鉴于该原虫对药物的耐药性不断增强,目前缺乏治疗替代方案。物种特异性蛋白酶对寄生虫的生存至关重要,可能是化疗靶点。然而,该原虫中蛋白酶的种类仍研究不足。在此,我们采用了多种组合生物信息学工具和策略来整理和鉴定该原虫基因组中编码全部蛋白酶的基因。我们鉴定出64种活性蛋白酶和25种无活性蛋白酶同源物。这些蛋白酶可分为半胱氨酸蛋白酶(=28种)、丝氨酸蛋白酶(=21种)、苏氨酸蛋白酶(=14种)、天冬酰胺蛋白酶(=7种)和金属肽酶(=19种),它们又总共被归入38个肽酶家族。该原虫和其他原虫蛋白酶种类的比较研究揭示了狭义和广义该原虫寄生虫之间的差异,这些差异反映了它们独特的进化史。总体而言,这些数据可能有助于指导未来的研究,增进我们对该原虫寄生虫生物学和致病性的理解,并探索将蛋白酶作为开发新型治疗干预措施的靶点。

相似文献

4
Lactate Dehydrogenase as a Potential Therapeutic Drug Target to Control .乳酸脱氢酶作为一种潜在的治疗药物靶点来控制。
Front Cell Infect Microbiol. 2022 Apr 19;12:870852. doi: 10.3389/fcimb.2022.870852. eCollection 2022.
6
Elimination of Is Dependent on Intraerythrocytic Killing and CD4 T Cells.清除依赖于红细胞内杀伤作用和CD4 T细胞。
J Immunol. 2017 Jul 15;199(2):633-642. doi: 10.4049/jimmunol.1601193. Epub 2017 Jun 12.
8
Identity of the causal agents of human babesiosis in Europe.欧洲人类巴贝斯虫病病原体的鉴定。
Int J Med Microbiol. 2006 May;296 Suppl 40:131-6. doi: 10.1016/j.ijmm.2006.01.029. Epub 2006 Mar 9.

本文引用的文献

2
Plasmepsin-like Aspartyl Proteases in .疟原虫中的类组织蛋白酶D天冬氨酸蛋白酶
Pathogens. 2021 Sep 26;10(10):1241. doi: 10.3390/pathogens10101241.
3
Optimization of an Evaluation Method for Anti-Babesia microti Drug Efficacy.优化抗巴贝西虫药物疗效评价方法。
Acta Trop. 2022 Jan;225:106179. doi: 10.1016/j.actatropica.2021.106179. Epub 2021 Oct 8.
4
Treatment of Human Babesiosis: Then and Now.人类巴贝斯虫病的治疗:过去与现在
Pathogens. 2021 Sep 1;10(9):1120. doi: 10.3390/pathogens10091120.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验